Who is sponsoring NCT01524497?

NCT01524497 is sponsored by Lee's Pharmaceutical Limited.

What condition does NCT01524497 study?

NCT01524497 studies Depression.

What drugs are being tested in NCT01524497?

Interventions: Trazodone, Placebo.

What is the status of NCT01524497?

NCT01524497 is currently COMPLETED.

Last reviewed 2014-10-14 · How we verify

A Clinical Study on Efficacy And Safety of Trazodone Hydrochloride Prolonged-Release Tablets for Treatment of Depression A Multicenter, Randomized, Double-Blind, Parallel Controlled Study

NCT01524497 Phase 2/Phase 3 COMPLETED

This is a multicenter, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of trazodone hydrochloride prolonged-release tablets for treatment of depression in Chinese population.

Details

Lead sponsor	Lee's Pharmaceutical Limited
Phase	Phase 2/Phase 3
Status	COMPLETED
Enrolment	382
Start date	2011-11
Completion	2013-11

Conditions

Depression

Interventions

Trazodone
Placebo

Primary outcomes

Change in Hamilton Depression Rating Scale-17 score — six weeks
17-item Hamilton Depression Rating scale were evaluated at the basemline and six weeks after treatment, the changes were recorded and used as primary outcome measurement.

Countries

China